ÂÜÀòÂÒÂ×

Martin Mumenthaler is currently serving as the Sr. Director of Clinical Sciences at Denovo Biopharma, where Martin is responsible for clinical protocol development and preparation for CNS trials, overseeing vendors and CROs, managing the MSL team, and participating in pharmacovigilance activities. Prior to this role, Martin held positions at various pharmaceutical companies such as FOXO BioScience as a Medical Consultant, Alkermes as the Director of Medical Affairs Engagement, XenoPort, Inc. as the Director of Clinical Development, and Iroko Pharmaceutical, LLC as the Regional Director of Field Medical Affairs. With a background in pharmacology and neuroscience research, Martin has a strong foundation in clinical science and has made significant contributions in the areas of substance use disorders, addiction, and pain management.